Clinical Trial Update: A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating IC14 for acute respiratory distress syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• IC14

Snippet

Sponsor: Implicit Bioscience | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: WITHDRAWN